Daara Patel on why genericisation of medicines as an initiative will not work in India

By EP News Bureau on June 2, 2017

Related Posts

Panel Discussion: The Bengaluru Bet: How GCCs are redefining India Pharma Inc

Panel Discussion: The biopharma pivot: Can India move from manufacturing medicines to inventing them?

Mr Loganathan S, AVP, Onesource Biopharma

Panel Discussion: The new innovation economy: Building the ecosystem behind the molecule

Dr Pravin Mhapankar, Director, Thermolab Scientific Equipments

Mr Prashanth Bajaj, Business Unit Director, Lindstrom Services India

Mr Vasudevan (Vasu) Ramanujam, Global Business Head, Innovation Acceleration Services, UST